Advancing Glioblastoma Treatment: Challenges and Opportunities of Immune Checkpoint Inhibition
Mohamed Hussein & El-Shimaa Ali · Asian Journal of Medicine and Health · 2025
Glioblastoma is the most aggressive and common malignant brain tumor in adults, with poor prognosis despite improvements in standard treatments such as surgery, radiation, and chemotherapy with temozolomide. Immune checkpoint inhibitors have emerged as a promising approach to str...
Open access
Research Article
10.9734/ajmah/2025/v23i11160